ebomi
Colour theme
Sign in
Insider · CIK 0001253170

Akkaraju Srinivas

CIK 0001253170 Name as filed on the most recent filing

Filed as Akkaraju Srinivas (92)

227 transaction lines · from 92 filings · filed 2004-06-04 to 2026-05-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

188 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-12-08 P, Open-market purchase Histogenics CorpHSGX 5,502,178, acquired Open Form 4 filing 0001144204-14-073112
2014-11-12 P, Open-market purchase Intercept Pharmaceuticals IncICPT 3 lines 334,387, acquired Open Form 4 filing 0001144204-14-067445
2014-03-26 P, Open-market purchase Versartis, Inc.VSAR 1,260,000, acquired Open Form 4 filing 0001181431-14-014394
2014-01-16 S, Open-market sale Intercept Pharmaceuticals IncICPT 870,805, disposed Open Form 4 filing 0001144204-14-002903
2013-12-18 S, Open-market sale Intercept Pharmaceuticals IncICPT 14,437, disposed Open Form 4 filing 0001144204-13-068270
2013-06-14 S, Open-market sale Seattle Genetics Inc /WASGEN 163,750, disposed Open Form 4 filing 0001203311-13-000050
2013-05-10 S, Open-market sale Seattle Genetics Inc /WASGEN 650,430, disposed Open Form 4 filing 0001203311-13-000030
2013-02-19 S, Open-market sale MEI Pharma, Inc.MEIP 2,040,000, disposed Open Form 4 filing 0001012975-13-000059
2013-02-15 S, Open-market sale MEI Pharma, Inc.MEIP 1,301,685, disposed Open Form 4 filing 0001012975-13-000059
2012-10-16 P, Open-market purchase Intercept Pharmaceuticals IncICPT 10,500,000, acquired Open Form 4 filing 0001144204-12-056461
2012-07-24 P, Open-market purchase Durata Therapeutics, Inc.DRTX 7,058,817, acquired Open Form 4 filing 0001181431-12-042325
2012-06-27 S, Open-market sale Synageva Biopharma CorpGEVA 12,444,005, disposed Open Form 4 filing 0001012975-12-000219
2012-06-26 S, Open-market sale Synageva Biopharma CorpGEVA 1,157,661, disposed Open Form 4 filing 0001012975-12-000219
2012-03-19 S, Open-market sale Synageva Biopharma CorpGEVA 11,141,149, disposed Open Form 4 filing 0001012975-12-000090
2011-07-19 S, Open-market sale Transcept Pharmaceuticals IncTSPT 367,198, disposed Open Form 4 filing 0001012975-11-000216
2011-07-18 S, Open-market sale Transcept Pharmaceuticals IncTSPT 729,259, disposed Open Form 4 filing 0001012975-11-000216
2011-07-14 S, Open-market sale Transcept Pharmaceuticals IncTSPT 202,245, disposed Open Form 4 filing 0001012975-11-000214
2011-07-13 S, Open-market sale Transcept Pharmaceuticals IncTSPT 843,833, disposed Open Form 4 filing 0001012975-11-000214
2010-10-19 P, Open-market purchase World Heart CorpWHRT 4,999,999, acquired Open Form 4 filing 0001012975-10-000373
2010-01-26 P, Open-market purchase World Heart CorpWHRT 2,000,003, acquired Open Form 4 filing 0001012975-10-000025
2009-08-18 P, Open-market purchase Seattle Genetics Inc /WASGEN 56,260, acquired Open Form 4 filing 0001012975-09-000261
2009-06-25 P, Open-market purchase Seattle Genetics Inc /WASGEN 3 lines 50,633, acquired Open Form 4 filing 0001012975-09-000180
2008-09-22 S, Open-market sale Seattle Genetics Inc /WASGEN 7 lines 237,907, disposed Open Form 4 filing 0001144204-08-054134
2008-09-19 S, Open-market sale Seattle Genetics Inc /WASGEN 7 lines 1,117,247, disposed Open Form 4 filing 0001144204-08-054338
2008-09-19 S, Open-market sale Seattle Genetics Inc /WASGEN 6 lines 471,520, disposed Open Form 4 filing 0001144204-08-053909
2008-09-18 S, Open-market sale Seattle Genetics Inc /WASGEN 102,214, disposed Open Form 4 filing 0001144204-08-054297
2008-09-18 S, Open-market sale Seattle Genetics Inc /WASGEN 29,436, disposed Open Form 4 filing 0001144204-08-054297
2008-09-18 S, Open-market sale Seattle Genetics Inc /WASGEN 4,436, disposed Open Form 4 filing 0001144204-08-054297
2008-09-18 S, Open-market sale Seattle Genetics Inc /WASGEN 39,757, disposed Open Form 4 filing 0001144204-08-054297

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
*, Other
Other

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 68
  • Open-market sale 120
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. AKKARAJU SRINIVAS, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001253170

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.